Consensus Beximco Pharmaceuticals Limited London S.E.

Equities

BXP

US0885792061

Market Closed - London S.E. Other stock markets 11:35:12 2024-04-26 am EDT			5-day change	1st Jan Change
36.5 ^GBX	0.00%		-1.35%	-12.05%

Mar. 04	Beximco names Iqbal Ahmed as managing director	AN
Jan. 30	Beximco Pharmaceuticals to strengthen portfolio as interim profit up	AN

Evolution of the average Target Price on Beximco Pharmaceuticals Limited

Price target over the last 5 years

History of analyst recommendation changes

448c0e91dcb50a.7Uj4Er3lQzrkQD2-JgRO28nk5wtHjotV2hRcYeRqQWg.lCe9Zs2QMkiNdgjxZFAcgafQt0x0yMEZsUZrKoAMGCDZIZZc6NIoaI4GUg~ee688bffd7088442835bbd7e1f3e8e9a

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

116.1 BDT

Average target price

153.5 BDT

Spread / Average Target

+32.21%

High Price Target

157 BDT

Spread / Highest target

+35.23%

Low Price Target

150 BDT

Spread / Lowest Target

+29.20%

Consensus detail

Consensus revision (last 18 months)

Ratings for Beximco Pharmaceuticals Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar